What is the recommended dosing, administration schedule, monitoring, and contraindications for Rectogesic (glyceryl trinitrate 0.2% ointment) in an adult with chronic anal fissure after conservative measures have failed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rectogesic for Chronic Anal Fissure

For adults with chronic anal fissure after failed conservative measures, apply glyceryl trinitrate 0.2% ointment (approximately 1.5-2 cm) to the anal canal twice daily for 6-8 weeks, though be aware that healing rates are modest (25-60%) and headaches occur frequently. 1

Dosing and Administration

Standard regimen:

  • Dose: 1.5-2 cm of 0.2% GTN ointment applied to the anal canal
  • Frequency: Twice daily (morning and evening)
  • Duration: 6-8 weeks for optimal effect 2
  • Application technique: Use the provided applicator device or finger cot; apply directly to the anal canal, not just perianal skin 3

The evidence shows no benefit to extending treatment beyond 40 days—healing and pain improvement plateau at 6 weeks, with no additional gains from continuing to 80 days 2. If the fissure hasn't healed by 8 weeks, further GTN therapy is unlikely to help.

Expected Outcomes and Realistic Expectations

Healing rates are variable and modest:

  • Early trials reported 70-80% healing, but more rigorous studies show only 25-50% healing rates 1
  • One well-designed study found 60.6% healing at 8 weeks with GTN versus 97% with lateral internal sphincterotomy 4
  • Recurrence is common: approximately 25-45% of initially healed fissures recur after stopping treatment 4, 5

This is a critical point—GTN is significantly less effective than surgery, and patients need to understand this upfront. The AGA guidelines acknowledge these "tempered" results compared to early enthusiasm 1.

Mechanism and Monitoring

How it works: GTN causes reversible chemical sphincterotomy by decreasing resting anal pressure through nitric oxide-mediated smooth muscle relaxation. Maximum anal resting pressure typically drops from ~120-130 cm H₂O to ~70-90 cm H₂O within 20 minutes of application 6, 5.

Follow-up schedule:

  • Assess at 2 weeks for early symptom improvement (pain reduction should be evident)
  • Re-evaluate at 6 weeks for healing
  • Final assessment at 8 weeks to determine treatment success or failure
  • If no improvement by 2-4 weeks, consider alternative therapy 3, 2

No routine pressure monitoring is needed in clinical practice—symptom improvement and visual healing are the endpoints.

Side Effects and Contraindications

Headache is the dominant side effect:

  • Occurs in approximately 50-65% of patients 7, 8
  • Severe enough to discontinue treatment in 8-20% of cases 3, 9, 8
  • Usually develops within the first 2 weeks
  • May improve with continued use or dose reduction

Contraindications and precautions:

  • Avoid concomitant use with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil)—risk of severe hypotension
  • Caution with other vasodilators or antihypertensive medications
  • Hypotension can occur, particularly in volume-depleted patients
  • Pregnancy/breastfeeding: insufficient data, use only if clearly needed 10
  • For external use only—do not insert mechanical applicators into the rectum 10

When GTN Fails or Is Inappropriate

Consider proceeding directly to surgery if:

  • Pain is intolerable and requires immediate relief
  • Patient has compromised sphincter function (GTN won't help and surgery risks incontinence)
  • Patient refuses or cannot tolerate medical therapy
  • Fissure shows no improvement after 2-4 weeks of compliant GTN use

After GTN failure (no healing at 8 weeks):

  • Lateral internal sphincterotomy remains the gold standard with 97% healing rates 4
  • Botulinum toxin injection is an alternative (75-95% healing) with lower morbidity than surgery 1
  • Recurrent fissures after initial GTN healing should proceed to definitive therapy

Critical Clinical Pitfalls

  1. Poor compliance is a major failure factor 4—twice-daily application for 6-8 weeks is burdensome, and many patients discontinue prematurely

  2. The definition of "chronic" matters—studies with loose chronicity criteria (symptoms >8 weeks alone) showed high placebo healing rates (37.5%), suggesting many "chronic" fissures are actually still acute 7. True chronic fissures have morphological features: exposed internal sphincter muscle, sentinel tag, hypertrophied papilla, or fibrosis 1

  3. Off-midline fissures require investigation for Crohn's disease, HIV/AIDS, tuberculosis, syphilis, or malignancy before any treatment 1

  4. GTN is labor-intensive for both patient and physician with modest results—the AGA acknowledges it as "acceptable" but "not entirely proven" 1

Positioning in Treatment Algorithm

GTN's role is as a bridge therapy for patients who want to avoid surgery or have failed conservative measures (fiber, fluids, sitz baths, topical analgesics) but aren't ready for definitive surgical management. Its low morbidity profile (no permanent sphincter damage) justifies its use as first-line pharmacotherapy 1, but patients must understand the trade-off: lower efficacy, high recurrence rates, and frequent headaches versus the rapid, definitive results of sphincterotomy with its small but permanent incontinence risk.

The practical reality: Most patients who fail GTN will ultimately require lateral internal sphincterotomy 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.